Lower Price will arrives for Zytiga Prostate cancer drug – Laredo Daily News

Lower Price will arrives for Zytiga Prostate cancer drug – Laredo Daily News

Zytiga for men with metastatic prostate cancer (mCRPC) that's relapsed after hormone treatment. The drug had previously been approved in 2012 for men who have already had chemotherapy, but was rejected for use before chemotherapy in August 2014.

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Write a comment

*